CRBP vs. LASE
CRBP (Corbus Pharmaceuticals Holdings, Inc.) and LASE (Laser Photonics Corporation) are both stocks. CRBP operates in Biotechnology (Healthcare), while LASE operates in Specialty Industrial Machinery (Industrials). Over the past 3 years, CRBP returned -1.85%/yr vs -10.69%/yr for LASE. At a 0.07 correlation, their price movements are largely independent.
Performance
CRBP vs. LASE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBP achieves a 2.09% return, which is significantly higher than LASE's -13.77% return.
CRBP
- 1D
- 0.61%
- 1M
- -26.78%
- YTD
- 2.09%
- 6M
- -0.36%
- 1Y
- 0.85%
- 3Y*
- -1.85%
- 5Y*
- -32.59%
- 10Y*
- -21.17%
LASE
- 1D
- -8.19%
- 1M
- 137.25%
- YTD
- -13.77%
- 6M
- -17.44%
- 1Y
- 5.97%
- 3Y*
- -10.69%
- 5Y*
- —
- 10Y*
- —
CRBP vs. LASE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 2.09% | -31.02% | 95.36% | 82.20% | -36.78% |
LASE Laser Photonics Corporation | -13.77% | -57.27% | 389.83% | -42.16% | -59.20% |
Correlation
The correlation between CRBP and LASE is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2022 | 0.07 |
Fundamentals
CRBP:
-$5.98
LASE:
-$0.48
CRBP:
$0.00
LASE:
$7.14M
CRBP:
-$149.00K
LASE:
$2.22M
CRBP:
-$61.36M
LASE:
-$8.37M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBP vs. LASE — Risk / Return Rank
CRBP
LASE
CRBP vs. LASE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Laser Photonics Corporation (LASE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRBP | LASE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.01 | ||
| Sortino ratioReturn per unit of downside risk | -1.39 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.25 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.01 | 0.07 | -0.05 |
| Martin ratioReturn relative to average drawdown | 0.02 | 0.10 | -0.08 |
Loading charts...
Drawdowns
CRBP vs. LASE - Drawdown Comparison
The maximum CRBP drawdown since its inception was -99.31%, roughly equal to the maximum LASE drawdown of -96.80%. Use the drawdown chart below to compare losses from any high point for CRBP and LASE.
Loading charts...
Drawdown Indicators
| CRBP | LASE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.31% | -96.80% | -2.51% |
Max Drawdown (1Y)Largest decline over 1 year | -61.88% | -90.76% | +28.88% |
Max Drawdown (3Y)Largest decline over 3 years | -92.01% | -96.80% | +4.79% |
Max Drawdown (5Y)Largest decline over 5 years | -96.55% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.31% | — | — |
Current DrawdownCurrent decline from peak | -97.32% | -88.67% | -8.65% |
Average DrawdownAverage peak-to-trough decline | -66.11% | -70.81% | +4.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.86% | 62.70% | -20.84% |
Volatility
CRBP vs. LASE - Volatility Comparison
The current volatility for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is 43.31%, while Laser Photonics Corporation (LASE) has a volatility of 113.91%. This indicates that CRBP experiences smaller price fluctuations and is considered to be less risky than LASE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBP | LASE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 43.31% | 113.91% | -70.60% |
Volatility (6M)Calculated over the trailing 6-month period | 60.26% | 150.27% | -90.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.71% | 236.02% | -154.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 159.23% | 186.92% | -27.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 129.12% | 186.92% | -57.80% |
Dividends
CRBP vs. LASE - Dividend Comparison
Neither CRBP nor LASE has paid dividends to shareholders.
Financials
CRBP vs. LASE - Financials Comparison
This section allows you to compare key financial metrics between Corbus Pharmaceuticals Holdings, Inc. and Laser Photonics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRBP and LASE have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LASE has higher volatility (113.91%) compared to CRBP (43.31%). In terms of maximum drawdown, CRBP dropped -99.31% vs LASE's -96.80%.
LASE currently has the higher Sharpe Ratio (0.03 vs 0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBP and LASE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer